Patent ID: 9423401
Filing Date: 2016-08-23
CPC Classification: C07K,G01N

Claim Text:
1. A method for treating cancer in a subject, comprising a) obtaining a biological sample from the subject and applying said biological sample to a sialoglycan-microarray, said sialoglycan-microarray comprising at least four sialoglycan pairs, each of said at least four sialoglycan pairs differing only in the sialic acid residue present, wherein a first sialoglycan from each pair comprises Neu5Ac and a second sialoglycan from each pair comprises Neu5Gc, and wherein four sialoglycans of said at least 4 sialoglycan pairs comprise: b) determining, in said biological sample, the level of one or more antibody, wherein said one or more antibody binds to at least one sialoglycan selected from the group consisting of: c) comparing the level of said one or more antibody determined in step b) with the level of one or more antibody a control normal sample, wherein said one or more antibody in a control normal sample has the same binding specificity as said one or more antibody determined in step b),